New Study finds that increased levels of certain lipids in the brain may indicate #ParkinsonsDisease. Technology like Simoa that can identify these #biomarkers pre-symptom will be key for #earlydetection and can help researchers generate novel treatments https://bit.ly/2rwxIRv

05.18.2018

A new study from @UCLA shows promise for #cambinol in slowing the effects of #Alzheimers. We need to accelerate #earlydetection methods for the disease, using technologies like Simoa to detect early signs before symptoms appear https://bit.ly/2KHlbDL via @mnt

05.16.2018

Scientists have reported the #protein CKAP4 as a potential blood #biomarker for #lungcancer. Through tech like Simoa that can measure #biomarkers like these with ultra-sensitivity providers may be able to #earlydetect the disease with unparalleled accuracy https://bit.ly/2KMW02s

05.14.2018

New research published in @Neuro_Trauma shows that our Simoa 4-plex assay provides simultaneous quantification of GFAP, UCH-L1, NF-L and #tau, and may be clinically useful in the diagnosis of #TBIs as well as identifying different types of cellular injury. https://bit.ly/2HNPvup

05.13.2018

Preliminary results show promise for #earlydetection of #autism using cerebrospinal fluid #biomarkers in monkeys. Technology like Simoa may become critical for measuring these biomarkers at ultra-sensitive levels to identify the condition in humans https://bit.ly/2rhIXhm